{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T04:21:50Z","timestamp":1729052510663},"reference-count":0,"publisher":"American Association for Laboratory Animal Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["comp med"],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:p>We collected historical control data derived from pretreatment ophthalmologic examinations of young (4 to 7 wk of age) Sprague\u2013Dawley (Crl:CD[SD]) male, (2033, 42 lots) and female (1322, 32 lots) rats used in toxicity studies at our facility from 2004 through 2015. Ophthalmologic\n examination of male and female rats by using a binocular indirect ophthalmoscope and slit lamp revealed high incidences of corneal opacity (61% and 60%, respectively), lenticular opacity (43% and 47%), persistent hyaloid artery (21% and 17%), and retinal folds (27% and 27%). All other ocular\n abnormalities of the globe, conjunctiva, cornea, anterior chamber, lens, iris, vitreous, and choroid or retina occurred at incidences of less than 5%. Corneal opacities were localized mainly in the corneal nasal (38% and 37%) and paracentral (32% and 33%) areas, and lenticular opacities predominantly\n occurred in the nuclear area (31% and 34%). We then compared the incidences of spontaneous ocular abnormalities between the first (2004 through 2009) and second (2010 through 2015) 6-y periods. Corneal opacity and persistent hyaloid artery in male and female rats occurred more frequently during\n the second 6-y than during the first (corneal opacity, second period: male, 68%; female, 66%; corneal opacity, first period: 49% and 51%; persistent artery, second period, 26% and 23%; persistent artery, first period; 12% and 10%). These results support the importance of updating historical\n control data regularly and providing useful information for toxicologists and ophthalmologists to differentiate treatment-related changes from spontaneous lesions.<\/jats:p>","DOI":"10.30802\/aalas-cm-19-000076","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T01:15:13Z","timestamp":1583198113000},"page":"140-144","source":"Crossref","is-referenced-by-count":5,"title":["Spontaneous Ocular Abnormalities in Sprague\u2013Dawley Rats"],"prefix":"10.30802","volume":"70","author":[{"given":"Junya","family":"Morita","sequence":"first","affiliation":[{"name":"Drug Safety and Pharmacokinetics Laboratories, Taisho Pharmaceutical Research Center, Saitama, Japan;, Email: ju-morita@taisho.co.jp"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiro","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Drug Safety and Pharmacokinetics Laboratories, Taisho Pharmaceutical Research Center, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Sugihara","sequence":"additional","affiliation":[{"name":"Drug Safety and Pharmacokinetics Laboratories, Taisho Pharmaceutical Research Center, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Wakamatsu","sequence":"additional","affiliation":[{"name":"Drug Safety and Pharmacokinetics Laboratories, Taisho Pharmaceutical Research Center, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Drug Safety and Pharmacokinetics Laboratories, Taisho Pharmaceutical Research Center, Saitama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"12258","container-title":["Comparative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/aalas\/cm\/2020\/00000070\/00000002\/art00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T04:41:17Z","timestamp":1595565677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.30802\/AALAS-CM-19-000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4,1]]}},"alternative-id":["1532-0820(20200401)70:2L.140;1-"],"URL":"https:\/\/doi.org\/10.30802\/aalas-cm-19-000076","relation":{},"ISSN":["1532-0820"],"issn-type":[{"type":"print","value":"1532-0820"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}